Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2016-02-03 Director's Dealing
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Tony Ho - Change of Director's Interest Notice 2 pages 307.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's acquisition of shares and options, including dates, quantities, and consideration paid. The content focuses on personal share transactions by a company director, which aligns with insider trading disclosures. There is no financial performance data, management discussion, or report publication. The document length is 3622 characters, which is typical for a director's dealing notice. Therefore, the document fits the category of Director's Dealing (DIRS).
2016-02-03 English
Appendix 4C - December Quarterly 6 pages 392.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'December 2015 Quarterly Update and Appendix 4C' and contains detailed financial data for the quarter ended 31 December 2015, including cash flow statements, operating results, and other financial metrics. It is a comprehensive financial report for a period shorter than a full fiscal year (quarterly). The presence of Appendix 4C, which is a standard quarterly report format for entities admitted on the basis of commitments, further confirms this. The document is about 9,249 characters long, which is sufficient to contain substantive financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q2 2016
2016-01-20 English
Results of Annual General Meeting 2 pages 259.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a letter addressed to the Australian Securities Exchange Compliance, dated 20 November 2015, reporting the results of the 2015 Annual General Meeting (AGM) resolutions. It lists the resolutions voted on, the voting results (for, against, abstain, excluded), and confirms that all resolutions were passed. The content is focused on the official announcement of voting outcomes from the AGM, not the AGM materials themselves or the full annual report. The document length is short (1845 characters), and it is clearly an announcement of voting results rather than a detailed report or presentation. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-11-19 English
Mariposa Health Inc. Investment Update 2 pages 334.3KB
Capital/Financing Update Classification · 95% confidence The document is an update from Bioxyne Limited regarding a licensing agreement and investment progress related to Mariposa Health Inc. It discusses commercial agreements, deferred consideration, royalties, and investment valuation. There is no detailed financial data, comprehensive financial statements, or management discussion of financial results. The document is relatively short (3379 characters) and serves as a corporate update on a specific transaction and investment status rather than a full financial report or earnings release. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory filing or certification. The content is best classified as a Capital/Financing Update (CAP) because it provides information on the company's investment and contingent consideration related to a licensing deal and subsidiary sale.
2015-11-10 English
Change of Director's Interest Notice - Patrick Ford 2 pages 475.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and transaction details. This is a report of personal share transactions by a company director, which fits the definition of 'Director's Dealing'. The document length is 3542 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is 'DIRS'.
2015-11-01 English
Appendix 4C - September Quarterly 6 pages 493.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'September 2015 Quarterly Update and Appendix 4C' and contains detailed financial data for the quarter ended 30 September 2015, including cash flow statements, operating results, and other financial metrics. It is an unaudited quarterly report with substantive financial data and analysis, consistent with a quarterly or interim financial report. The presence of the Appendix 4C, which is a standard quarterly cash flow report for entities admitted on the basis of commitments, further confirms this classification. The document is 8567 characters long, which is sufficient to contain detailed financial information rather than just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2015-10-28 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.